Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.90m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Warwick Acoustics Update

7 Oct 2020 07:00

RNS Number : 2990B
Mercia Asset Management PLC
07 October 2020
Β 

Β 

RNS REACH

7 October 2020

Β 

Mercia Asset Management PLC

("Mercia" or "the Group")

Β 

Warwick Acoustics Update

Β 

Β£2.1million of syndicated investment and Β£0.4million innovation grant

Β 

MerciaΒ Asset Management PLC (AIM: MERC),Β the proactive, regionally focused, specialist asset managerΒ with c.Β£800 million of assets under management, is pleased to announce that its direct portfolio company Warwick Acoustics Limited ("Warwick Acoustics", "the Company") has secured Β£2.1million of recent syndicated investment, including Β£0.5million from Mercia. The Company has also recently won a Β£0.4million grant from Innovate UK, in conjunction with the University of Warwick.

Β 

Warwick Acoustics is one of Mercia's earliest investments, having received its first investment through Mercia's managed funds in January 2013 before becoming a balance sheet direct investment in December 2014. As at 31 March 2020, Mercia held a 52.9% fully diluted direct holding in Warwick Acoustics.

Β 

The Company, which is based in state-of-the-art facilities at the Mira Technology Park in Warwickshire, develops highly innovative audio products for both the automotive audio market and the personal and studio headphone market.

Β 

Despite the challenges in the automotive industry as a result of the COVID-19 pandemic, Warwick Acoustics is continuing to make good progress in both the automotive and headphone markets.

Β 

Reflective of this progress the Company was recently awarded a grant from Innovate UK to support the development of lower cost designs for its lightweight, highly power-efficient ElectroAcoustic Panels. Targeted manufacturing cost reductions will enable the Company to significantly expand the reach of its technology from premium to mass market vehicles.

Β 

Combined, this significant funding provides sufficient development capital to support the Company's expansion plans for at least the next 15 months.

Β 

Mike Grant, Chief Executive Officer at Warwick Acoustics, commented:Β 

"The COVID-19 pandemic has created new challenges for the automotive industry. Government regulations and new cash flow pressures are requiring OEMs to rationalise model ranges to reduce costs and to focus on accelerating developments of Electric Vehicles ("EVs"). This in turn has placed a premium on light-weighting and power-efficient technologies in order to increase range and improve the attractiveness of EVs.

Β 

"The recent investment in Warwick Acoustics and the award of an Innovate UK grant under highly competitive conditions recognise the class leading weight savings and power efficiency of our high- performance, patented ElectroAcoustic Panel technology. With this combined funding, we are in an excellent position to take the next step in our goal of disrupting the way in which in-car entertainment is delivered."

Β 

Mark Payton, Chief Executive Officer at Mercia, commented:Β 

"We believe Warwick Acoustics has a compelling product set and is well positioned to capitalise on both the increasing demands from the automotive industry for smaller, lightweight, quality audio as well as similar trends from consumers. We are pleased to continue supporting the business in delivering on these commercial opportunities through a meaningful syndication. Businesses such as Warwick Acoustics have significant potential to help the automotive industry by reducing weight, space and costs within an emission-focused regulatory environment. We therefore continue to be encouraged by the business's significant potential to assist the increasingly innovative automotive industry."

Β 

-Ends-

Β 

For further information, please contact:

Β 

Mercia Asset Management PLC

MarkΒ Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

Β 

+44 (0)330 223 1430

Β 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel, Richard Andrews

Β 

Β 

Β 

N+1 Singer (Joint Broker)

Β 

Harry Gooden, James Moat

Β 

+44 (0)20 7496 3000

Β 

Β 

FTI Consulting

Β 

Β +44 (0)20 3727 1051

Tom Blackwell, Louisa Feltes, Shiv Talwar

Β 

mercia@fticonsulting.com

Β 

Β 

About Mercia Asset Management PLC:

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of balance sheet, venture, private equity and debt capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

Β 

The Group has a strongΒ UKΒ footprint through its regional offices, 19 university partnerships and extensive personal networks, providing it with access to high-quality deal flow. Mercia currently has c.Β£800millionΒ of assets under management and, since its IPO in December 2014, has invested overΒ Β£96millionΒ into its direct investment portfolio.

Β 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRAFLFITIFLRIII
Date   Source Headline
24th Sep 20197:00 amRNSAGM Statement
10th Sep 20197:00 amRNS£7.5million syndicated investment into Voxpopme
1st Aug 20197:00 amRNSGrant of Options
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.